Exelixis, Inc. (EXEL)

Nasdaq: EXEL · Biological Products, (No Diagnostic Substances) · Alameda, CA · filing with the SEC since 2000

Grade7.5

◀ Past 8.6● Present 8.5▶ Future 5.1

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in January.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period ending	Jan 2, 2026	Jan 3, 2025	Dec 29, 2023	Dec 30, 2022	Dec 31, 2021	Jan 1, 2021	Jan 3, 2020	Dec 28, 2018	Dec 29, 2017	Dec 31, 2016
Report filed	Feb 10, 2026	Feb 11, 2025	Feb 6, 2024	Feb 7, 2023	Feb 18, 2022	Feb 11, 2021	Feb 25, 2020	Feb 22, 2019	Feb 26, 2018	·
Revenue	2,320,126	2,168,701	1,830,208	1,611,062	1,434,970	987,538	967,775	853,826	452,477	191,454
Cost of revenue	83,697	76,216	72,547	57,909	52,873	36,272	33,097	26,348	15,066	6,552
Research and development	825,001	910,408	1,044,071	891,813	693,716	547,851	336,964	182,257	112,171	95,967
Selling, general and administrative	518,727	492,128	542,705	459,856	401,715	293,355	228,244	206,366	159,330^r	116,145
Total operating expenses	·	·	·	·	·	·	598,305	414,971	286,567	219,578
Total costs and expenses	1,447,935	1,564,084	1,659,323	1,409,578	1,148,304	877,478	598,305	414,971	·	·
Operating income	872,191	604,617	170,885	201,484	286,666	110,060	369,470	438,855	165,910	-28,124
Interest expense	·	·	·	·	·	·	0	0	8,679	33,060
Interest and investment income	69,213	77,156	86,543	33,065	7,672	19,865	27,959	12,840	4,883	·
Other income (expense), net	-198	-133	93	-197	-184	912	680	397	-3,537	4,863
Total non-operating income (expense)	·	·	·	·	·	·	28,639	13,237	-7,333	-42,098
Income before income taxes	·	·	·	·	·	130,837	398,109	452,092	158,577	-70,222
Income tax expense	158,636	160,373	49,756	52,070	63,091	19,056	77,097	-237,978	4,350	0
Net income	782,570	521,267	207,765	182,282	231,063	111,781	321,012	690,070	154,227	-70,222
Net income to common shareholders	·	·	·	·	·	·	321,012	690,070	153,860	·
Earnings per share, basic	2.88	1.80	0.65	0.57	0.73	0.36	1.06	2.32	0.52	·
Earnings per share, diluted	2.78	1.76	0.65	0.56	0.72	0.35	1.02	2.21	0.49	·
Earnings per share, basic and diluted	·	·	·	·	·	·	·	·	·	-0.28
Weighted average shares, basic	271,567	290,030	318,151	321,526	314,884	308,271	302,584	297,892	293,588	·
Weighted average shares, diluted	281,863	296,132	321,464	324,556	322,359	318,001	315,009	312,803	312,003	·
Weighted average shares, basic and diluted	·	·	·	·	·	·	·	·	·	250,531

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues

Cost of revenue what it cost to make or buy what it sold

us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Total costs and expenses every operating cost, the cost of revenue includedus-gaap:CostsAndExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing costus-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InterestIncomeOther

Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense

Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton EXEL · research, not advice